Infographics
-
Infographic: EU MDR – Touch Your Label Once
4/29/2019
Many companies are using the “Touch once” terminology to address the concerns of EU MDR and also the fact that the platforms that their labeling solution sits on and is validated against will be unsupported (depending on the platform) between 2020 and 2022. Labeling systems need to be compliant with EU MDR by 2020. Ensure you only touch your labels once, while addressing both impending deadlines.
-
Infographic: Medical Device Label Before And After EU MDR – 10 Sticking Points
4/29/2019
EU MDR introduces additional information that needs to be included on labels, forcing organizations to design new label templates that make room for data not previously part of the labeling system. It’s both a design and a data challenge, and they must quickly be addressed to avoid a sticky situation.
-
Infographic: EU MDR – Is the Industry Planning for It? Are You?
4/29/2019
In a recent survey conducted by PRISYM ID, 26% of respondents admitted that they have just started to think about EU MDR, 24% of respondents admitted that they haven’t started to think about EU MDR and 50% of respondents said they understood the implications and plans are in progress. This infographic presents top concerns with regards to EU MDR and what do they think about the areas likely to be affected and about the resources needed to implement the EU MDR.
-
Infographic: UDI Lessons Learnt
4/29/2019
The introduction of UDI requirements into the EU is good news for organizations that are already along the pathway of adopting systems and processes to support FDA UDI compliance. However, for those that aren’t – and indeed those that may have made only basic adjustments to their labeling infrastructure in response to the regulations – there are five key learnings that have emerged from PRISYM ID's UDI experience that may help inform best practice adoption with EU MDR.
-
Infographic: Can Vision Systems Safeguard Label Integrity
4/29/2019
Medical device and pharmaceutical organizations are constantly looking at ways to avoid labeling errors which are a major reason for FDA product recalls. In a recent survey conducted by PRISYM ID, 67% of respondents admitted that human error was the most frequent cause for their labeling errors and 45% frequently experienced quality issues throughout their label production process.